Boston Bio Systems Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 417872,
    "name": "Boston Bio",
    "stock_name": "Boston Bio",
    "full_name": "Boston Bio Systems Ltd",
    "name_url": "stocks-analysis/boston-bio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.50",
    "chg": 0.25,
    "chgp": "2.7%",
    "dir": 1,
    "prev_price": "9.25",
    "mcapval": "6.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531458,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE109B01019",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "3.44 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/boston-bio-417872-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Boston Bio?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-boston-bio-3704049",
        "imagepath": "",
        "date": "2025-11-15 00:23:21",
        "description": "Answer:\nThe historical performance of Boston Bio shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability.\n\nBreakdown:\nBoston Bio's net sales have seen a notable decline from 1.50 Cr in March 2016 to just 0.19 Cr in March 2025, with a complete absence of sales in the intervening years of March 2017, March 2018, and March 2024. The total operating income followed a similar trend, peaking at 1.50 Cr in March 2016 and dropping to 0.19 Cr in March 2025. The company has consistently reported no raw material costs or purchase of finished goods, indicating a lack of production activity. Total expenditure, however, increased to 0.74 Cr in March 2025, up from 0.14 Cr in March 2024, primarily driven by other expenses. This led to an operating profit (PBDIT) of -0.55 Cr in March 2025, reflecting a negative operating profit margin of -289.47%. The profit before..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3681594",
        "imagepath": "",
        "date": "2025-11-08 00:04:20",
        "description": "As of 07-Nov, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.75, which represents a decrease of 0.37 or 4.56%. The stock has been underperforming, having fallen consecutively for the last two days and showing a total return of -8.82% over the past week. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. There has also been a significant drop in investor participation, with delivery volume on 06 Nov falling by 59.78% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Boston Bio's short-term performance has significantly lagged behind the benchmark, the Sensex, which has only decreased by 0.86% over the same week. While the Sensex has sho..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3660066",
        "imagepath": "",
        "date": "2025-10-30 23:26:17",
        "description": "As of 30-Oct, Boston Bio Systems Ltd's stock price is currently at 8.39, reflecting an increase of 0.39 or 4.88%. The stock has shown strong performance recently, gaining 14.62% over the last three days and outperforming its sector by 3.91% today. The stock's delivery volume has also seen a significant rise of 160.05% compared to the 5-day average, indicating increased investor participation. Additionally, the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. There are no positive or negative factors explicitly mentioned, but the overall trends suggest a favorable sentiment towards the stock.\n\nIn the broader market context, Boston Bio's stock has outperformed the Sensex over the past week, with a return of +8.96% compared to the benchmark's slight decline of -0.18%. However, over the past month, while Boston Bio has gained +4..."
      }
    ],
    "total": 66,
    "sid": "417872",
    "stock_news_url": "https://www.marketsmojo.com/news/boston-bio-systems-417872"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI(Depositories and Participants)Regulations 2018 for the quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Dec-2025",
      "details": "Closure of Trading Window from 1st January 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change of Company Name",
      "datetime": "27-Nov-2025",
      "details": "Intimation under Regulation 30 of the SEBI (LODR) Regulation 2015 - Change in the Name of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Boston Bio?

2025-11-15 00:23:21

Answer: The historical performance of Boston Bio shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability. Breakdown: Boston Bio's net sales have seen a notable decline from 1.50 Cr in March 2016 to just 0.19 Cr in March 2025, with a complete absence of sales in the intervening years of March 2017, March 2018, and March 2024. The total operating income followed a similar trend, peaking at 1.50 Cr in March 2016 and dropping to 0.19 Cr in March 2025. The company has consistently reported no raw material costs or purchase of finished goods, indicating a lack of production activity. Total expenditure, however, increased to 0.74 Cr in March 2025, up from 0.14 Cr in March 2024, primarily driven by other expenses. This led to an operating profit (PBDIT) of -0.55 Cr in March 2025, reflecting a negative operating profit margin of -289.47%. The profit before...

Read full news article

Why is Boston Bio falling/rising?

2025-11-08 00:04:20

As of 07-Nov, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.75, which represents a decrease of 0.37 or 4.56%. The stock has been underperforming, having fallen consecutively for the last two days and showing a total return of -8.82% over the past week. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. There has also been a significant drop in investor participation, with delivery volume on 06 Nov falling by 59.78% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Boston Bio's short-term performance has significantly lagged behind the benchmark, the Sensex, which has only decreased by 0.86% over the same week. While the Sensex has sho...

Read full news article

Why is Boston Bio falling/rising?

2025-10-30 23:26:17

As of 30-Oct, Boston Bio Systems Ltd's stock price is currently at 8.39, reflecting an increase of 0.39 or 4.88%. The stock has shown strong performance recently, gaining 14.62% over the last three days and outperforming its sector by 3.91% today. The stock's delivery volume has also seen a significant rise of 160.05% compared to the 5-day average, indicating increased investor participation. Additionally, the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. There are no positive or negative factors explicitly mentioned, but the overall trends suggest a favorable sentiment towards the stock. In the broader market context, Boston Bio's stock has outperformed the Sensex over the past week, with a return of +8.96% compared to the benchmark's slight decline of -0.18%. However, over the past month, while Boston Bio has gained +4...

Read full news article

View All News